Ignite Creation Date:
2024-05-06 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05277207
Status:
COMPLETED
Last Update Posted:
2024-05-07
First Post:
2022-03-02
Brief Title:
Tobacco Cessation Treatment Preferences Among Veteran Smokers
Sponsor:
VA Office of Research and Development
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Tobacco Cessation Treatment Preferences Among Veteran Smokers CDA 17-005
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MESH
Brief Summary:
There are significant barriers to tobacco cessation treatment for patients and providers in specialty care clinical settings Specialty providers cite several barriers to delivering evidence-based tobacco cessation care including insufficient time and lack of training In addition a large proportion of patients who begin tobacco cessation treatment do not quit Use of healthcare technology ie telehealth electronic health record and computerized treatment algorithms based on patient data to improve patients ability to quit tobacco use The purpose of this study is to demonstrate the feasibility of a larger trial and to evaluate the acceptability of the intervention design Thirty participants will be assigned to receive either 1 a treatment that includes personalized counseling tobacco cessation medications and text messaging or 2 referral to Department of Veterans Affairs Quitline program plus SmokefreeVET a text messaging program
Detailed Description:
There are significant barriers to tobacco cessation treatment for patients and providers in specialty care clinical settings Specialty providers in general cite several prominent barriers to delivering evidence-based tobacco cessation care including insufficient time lack of training a perception of low motivation in their patients and concerns about the sensitivity of tobacco cessation discussions In addition a large proportion of patients who begin tobacco cessation treatment do not achieve initial abstinence Use of healthcare technology ie telehealth electronic health record and computerized treatment algorithms based on patient data to personalize treatment has the potential to increase patient engagement and proactively address treatment non-response The proposed randomized controlled trial is a two-arm experimental design to demonstrate the feasibility of a larger trial and the acceptability of the intervention design Participants N 30 will be stratified by clinic and randomized to either 1 the active treatment which includes personalized cognitive behavioral treatment personalized smoking cessation pharmacotherapy and test messaging support or 2 standard of care Department of Veterans Affairs Quitline telehealth intervention including 5 sessions of CBT plus SmokefreeVET text-messaging intervention
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None